XML 31 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Note 10 - Shareholders' Equity
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
10.
Shareholders
'
Equity
 
Repurchase Program
 
During the year ended
December 31, 2020,
the Company repurchased and retired
223,100
shares of its common stock for
$2,666,000.
During the year ended
December 31, 2019,
the Company repurchased and retired
683,910
shares of its common stock for
$2,548,000.
As of
December 31, 2020,
the Company had
$4,486,000
available to repurchase common shares under the repurchase program.
 
Option Activity
 
The
2004
Stock Option Plan (the
“2004
Plan”) is an equity compensation plan that provides for grants of stock options to eligible individuals.  The
2004
Plan is intended to recognize the contributions made to the Company by key employees of the Company, provide key employees with additional incentive to devote themselves to the future success of the Company and improve the ability of the Company to attract, retain and motivate individuals.  The
2004
Plan also is intended as an incentive to certain members of the Board of Directors of the Company to continue to serve on the Board of Directors and to devote themselves to the future success of the Company.
 
The
2004
Plan provides for a total of
5,000,000
common shares eligible for issuance.
 
Under the
2004
Plan, approximately
5,009,750
options had been granted as of
December 31, 2019.
Under the
2004
Plan, option grants have a
three
-year vesting period and, since
2005,
expire
no
later than the
fifth
anniversary from the date of grant. The exercise price of the options is determined based on the fair market value of the stock on the date of grant.
 
At the Company's
2020
Annual Meeting of Shareholders held on
June 9, 2020,
the Company's shareholders approved the Alpha Pro Tech, Ltd.
2020
Omnibus Incentive Plan (the
“2020
Incentive Plan”). The
2020
Incentive Plan provides for the grant of incentive and nonqualified stock options, stock appreciation rights, awards of restricted stock and restricted stock units, performance share awards, cash awards and other equity-based awards to employees (including officers), consultants and non-employee directors of the Company and its affiliates. A total of
1,800,000
shares of the Company's common stock are reserved for issuance under the
2020
Incentive Plan, plus the number of shares underlying any award granted under the
2004
Option Plan that expires, terminates or is cancelled or forfeited under the terms of the
2004
Option Plan. As a result of the approval of the
2020
Incentive Plan,
no
future equity awards will be made pursuant to the
2004
Option Plan. Although
no
new awards
may
be granted under the
2004
Option Plan, all previously granted awards under the
2004
Option Plan will continue to be governed by the terms of the
2004
Option Plan. As of
December 31, 2020,
8,912
restricted stock equity awards had been granted under the
2020
Incentive Plan, the compensation expense associated with the
one
year vest of these awards is
$6,000.
As of
December 31, 2020,
$102,000
of total unrecognized compensation cost related to the restricted stock grants was expected to be recognized over a weighted-average remainder period of
.942
years.
 
The following table summarizes option activity for the years ended
December 31, 2020
and
2019:
 
 
   
 
 
 
 
Weighted
 
   
 
 
 
 
Average
 
   
 
 
 
 
Exercise Price
 
   
Shares
   
Per Option
 
                 
Options outstanding, December 31, 2018
   
1,022,913
    $
2.69
 
Granted to employees and directors
   
370,000
     
3.59
 
Exercised
   
(66,499
)    
1.96
 
Canceled/expired/forfeited
   
-
     
-
 
Options outstanding, December 31, 2019
   
1,326,414
     
2.86
 
Granted to employees and directors
   
-
     
-
 
Exercised
   
(757,674
)    
2.64
 
Canceled/expired/forfeited
   
-
     
-
 
Options outstanding, December 31, 2020
   
568,740
     
3.37
 
Options exercisable, December 31, 2020
   
200,500
     
3.48
 
 
Stock options to purchase
568,740
and
1,326,414
shares of common stock were outstanding as of
December 31, 2020
and
2019,
respectively. All of the stock options were included in the computation of the weighted-average number of dilutive common shares outstanding for the year ended
December 31, 2020.
All except
455,000
of the stock options, which were anti-dilutive, were included in the computation of the weighted-average number of dilutive common shares outstanding for the year ended
December 31, 2019.
 
The fair values of the share-based compensation awards granted were estimated using the Black-Scholes option-pricing model with the following assumptions and weighted average fair values:
 
   
Stock Options
 
   
For the Years Ended December 31,
 
   
2020
   
2019
 
Exercise price
   
-
    $
3.59
 
Risk-free interest rate
   
-
     
2.23
%
Expected volatility
   
-
     
32.17
%
Expected life in years
   
-
     
4.25
 
Black-Scholes fair value
   
-
    $
1.06
 
 
The Company used the Black-Scholes option-pricing model to value the options. The Company uses historical data to estimate the expected term of the options. The risk-free interest rate for periods consistent with the expected term of the award is based on the U.S. Treasury rates in effect at the time of grant. The expected volatility is based on historical volatility. The Company uses an estimated dividend payout ratio of zero, as the Company has
not
paid dividends in the past and, at this time, does
not
expect to do so in the foreseeable future. The Company accounts for option forfeitures as they occur.
 
The following table summarizes information about stock options as of
December 31, 2020:
 
       
Options
Outstanding
   
Options
Exercisable
 
Range
of
Exercise
Prices
 
Options
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contract Life
(in years)
   
Aggregate
Intrinsic
Value
   
Options
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contract Life
(in years)
   
Aggregate
Intrinsic
Value
 
                                                                     
$1.58
-
$3.90
   
568,710
    $
3.37
     
2.84
    $
4,473,000
     
200,500
    $
3.48
     
2.63
    $
1,601,000
 
 
The intrinsic value is the amount by which the market value of the underlying common stock exceeds the exercise price of the respective stock options. The aggregate intrinsic value of stock options exercised during the years ended
December 31, 2020
and
2019
was
$10,772,000
and
$121,000,
respectively.
 
As of
December 31, 2020,
$227,000
of total unrecognized compensation cost related to stock options was expected to be recognized over a weighted-average remaining period of
1.16
years. Cash received from
757,674
options exercised for the year ended
December 31, 2020
was
$1,998,000.
 
Dividends
 
The holders of the Company's common stock are entitled to receive such dividends as
may
be declared by the Board of Directors of the Company from time to time to the extent that funds are legally available for payment thereof. The Company has never declared or paid any dividends on any of its outstanding shares of common stock. The Board of Directors' current policy is
not
to pay dividends but rather to use available funds to repurchase common shares in accordance with the Company's repurchase program and to fund the continued development and growth of the Company. Consequently, the Company currently has
no
plans to pay cash dividends in the foreseeable future.